Illuccix Kit
Product Images NDC 74725-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Illuccix (NDC 74725-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Telix Pharmaceuticals (us) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A flowchart illustrating the preparation process of gallium Ga 68 gozetotide injection using the ILLUCCIX kit. It shows the combination of 68Ga from GE FASTLab, sterile vacuumed reaction vial, gozetotide vial, and acetate buffer vial, followed by dilution, radiolabeling, and quality control steps.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
An illustration diagram outlining the preparation process for the ILLUCCIX kit. It shows the flow from generator elution using EZAG 68Ge/68Ga generator and hydrochloric acid, and dilution of gozetotide in acetate buffer, to the addition of gozetotide into a vial containing gallium-68, followed by radiolabeling and quality control steps assessing radiochemical purity, pH, and appearance.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
Process flow diagram for the preparation of gallium Ga 68 gozetotide injection using the ILLUCCIX kit. The diagram shows key components including the IRE 68Ge/68Ga generator with elution solution, sterile vacuumed reaction vial, gozetotide vial, and acetate buffer vial. It illustrates steps of generator elution, dilution of gozetotide in acetate buffer, addition of gozetotide into vial containing gallium-68, radiolabeling, and quality control assessment for radiochemical purity, pH, and appearance.*
FDA Label Image

Ffigure 4 (Ffigure 4)

Ffigure 4 (Ffigure 4)
Chemical structure of gallium Ga 68 gozetotide, the active ingredient in ILLUCCIX kit for injection, shown as a molecular diagram with labeled chemical bonds and functional groups.*
FDA Label Image

Illuccix-04 (Illuccix 04)

Illuccix-04 (Illuccix 04)
Packaging label for ILLUCCIX kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg/vial gozetotide by Telix Pharmaceuticals (US) Inc. The label is primarily navy blue and white with design elements including the product name, dosage strength, route as intravenous use, and usage instructions. The label includes information about the contents of the kit, the lot and expiry print area, and storage instructions.*
FDA Label Image

Illuccix-05 (Illuccix 05)

Illuccix-05 (Illuccix 05)
Box packaging label for ILLUCCIX kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg/vial gozetotide by Telix Pharmaceuticals (US) Inc. The label includes storage instructions, usage information for intravenous use only, and contents of the multi-dose kit. It features a blue and white color scheme with the Telix Pharmaceuticals logo and mentions configuration B for use with IRE Galli Eo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.